Yoshitaro Torii

3.5k total citations
12 papers, 186 citations indexed

About

Yoshitaro Torii is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Yoshitaro Torii has authored 12 papers receiving a total of 186 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Immunology. Recurrent topics in Yoshitaro Torii's work include Lung Cancer Research Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Immunotherapy and Immune Responses (2 papers). Yoshitaro Torii is often cited by papers focused on Lung Cancer Research Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Immunotherapy and Immune Responses (2 papers). Yoshitaro Torii collaborates with scholars based in Japan and United States. Yoshitaro Torii's co-authors include Takashi Yokoi, Tomoki� Ito, Hideki Amuro, Ryuichi Amakawa, Hiroyuki Sugimoto, Shirou Fukuhara, Makoto Ogata, Takayasu Kurata, Shosaku� Nomura and Rie Miyamoto and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Journal of Leukocyte Biology.

In The Last Decade

Yoshitaro Torii

12 papers receiving 184 citations

Peers

Yoshitaro Torii

IMMUN

ONCOL

PRM

PFM

DERMA

Xavier Heim France

Caterina Naclerio Italy

Bhuvana Srinivasan Australia

Yukiko Takakuwa Japan

Yueting Huang China

Iwona Brzosko Poland

Sheila Nair India

Vesna Júrčić Slovenia

E. Seyrek Türkiye

V. Martínez-Taboada Spain

Xavier Heim France

Yoshitaro Torii

36 ×0.4

IMMUN

20 ×0.3

ONCOL

54 ×1.4

PRM

54 ×1.6

PFM

12 ×0.4

DERMA

Citations per year, relative to Yoshitaro Torii Yoshitaro Torii (= 1×) peers Xavier Heim

Countries citing papers authored by Yoshitaro Torii

Since Specialization

Citations

This map shows the geographic impact of Yoshitaro Torii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshitaro Torii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshitaro Torii more than expected).

Fields of papers citing papers by Yoshitaro Torii

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshitaro Torii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshitaro Torii. The network helps show where Yoshitaro Torii may publish in the future.

Co-authorship network of co-authors of Yoshitaro Torii

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshitaro Torii. A scholar is included among the top collaborators of Yoshitaro Torii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshitaro Torii. Yoshitaro Torii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Yokoi, Takashi, Seigo Minami, Takayuki Shiroyama, et al.. (2019). A Phase II Study of Tailored-dose S-1 Plus Carboplatin Followed by Maintenance S-1 for Advanced Squamous Cell Lung Cancer: OSAKA-LCSG 1102. Internal Medicine. 58(10). 1405–1410. 4 indexed citations

Saito, Tomohito, Koji Tsuta, Hiroshi Matsui, et al.. (2017). Combined small cell lung carcinoma and giant cell carcinoma: a case report. SHILAP Revista de lepidopterología. 3(1). 52–52. 6 indexed citations

Nakaya, Aya, Takayasu Kurata, Takashi Yokoi, et al.. (2017). Retrospective analysis of single-agent nab-paclitaxel in patients with platinum-resistant non-small cell lung cancer. Molecular and Clinical Oncology. 7(5). 803–807. 7 indexed citations

Kurata, Takayasu, Aya Nakaya, Takashi Yokoi, et al.. (2017). Phase I/II study of erlotinib, carboplatin, pemetrexed, and bevacizumab in chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer harboring epidermal growth factor receptor mutation. Genes & Cancer. 8(5-6). 559–565. 5 indexed citations

Nakaya, Aya, Takayasu Kurata, Takashi Yokoi, et al.. (2016). Retrospective analysis of bevacizumab‐induced hypertension and clinical outcome in patients with colorectal cancer and lung cancer. Cancer Medicine. 5(7). 1381–1387. 29 indexed citations

Yokoi, Takashi, Yoshitaro Torii, Hiroyuki Sugimoto, et al.. (2014). Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer. Oncology Letters. 8(6). 2453–2457. 9 indexed citations

Amuro, Hideki, Tomoki� Ito, Rie Miyamoto, et al.. (2010). Statins, inhibitors of 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production. Arthritis & Rheumatism. 62(7). 2073–2085. 38 indexed citations

Sugimoto, Hiroyuki, Tomoki� Ito, Yoshitaro Torii, et al.. (2010). Thymic stromal lymphopoietin plays an adjuvant role in BCG-mediated CD8+ cytotoxic T cell responses through dendritic cell activation. Clinical Immunology. 136(2). 205–216. 10 indexed citations

Torii, Yoshitaro, Tomoki� Ito, Ryuichi Amakawa, et al.. (2008). Imidazoquinoline Acts as Immune Adjuvant for Functional Alteration of Thymic Stromal Lymphopoietin-Mediated Allergic T Cell Response. The Journal of Immunology. 181(8). 5340–5349. 21 indexed citations

10.

Yokoi, Takashi, Ryuichi Amakawa, H. Sugimoto, et al.. (2008). Mycobacterium bovis Bacillus Calmette-Guerin suppresses inflammatory Th2 responses by inducing functional alteration of TSLP-activated dendritic cells. International Immunology. 20(10). 1321–1329. 19 indexed citations

11.

Shimizu, Toshiki, Kazutaka Uehira, Takashi Yokoi, et al.. (2007). Hodgkin’s Reed-Sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4+CD25+Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cells. Journal of Leukocyte Biology. 82(3). 576–584. 36 indexed citations

12.

Kasuga, Ikuma, Makoto Yonemaru, Yoshitaro Torii, et al.. (1994). [A case of large cell carcinoma of the lung producing granulocyte colony-stimulating factor].. PubMed. 32(1). 73–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact